Press Release
Turkmenistan specialists implement a new effective method of testing for SARS-CoV-2
16 June 2021
- WHO Country Office in Turkmenistan, together with UNDP, completed a two-day training course for laboratory specialists on the use of the GeneXpert platform, which is recommended by WHO as one of the rapid molecular genetic testing methods for SARS-CoV-2.
The course was held at the Virological Reference Laboratory of the Center for Public Health and Nutrition of the Ministry of Health and Medical Industry of Turkmenistan (CPHN). Laboratory specialists from the CPHN, Center for the Prevention of Highly Dangerous Infections, and the National Tuberculosis Program participated in the training.
This training course was carried out by WHO as part of the implementation of the Plan for Preparedness and Response of Turkmenistan to Acute Infectious Disease.
With the support of UNDP, one GeneXpert device has been installed at the Virological Reference Laboratory of the CPHN, with WHO providing 1,000 test cartridges for the device to help with the qualitative detection of SARS-CoV-2.
UN entities involved in this initiative
WHO
World Health Organization
Goals we are supporting through this initiative
